SNC
IONS icon

Stifel Nicolaus & Co’s Ionis Pharmaceuticals IONS Stock Holding History

Stifel Nicolaus & Co’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$23.7M Sell
632,553
-41,639
-6% -$1.24M 0.39% 66
2013
Q2 		$18.1M Buy
+674,192
New +$14.3M 0.33% 81

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stifel Nicolaus & Co's IONS Position: Q3 2013 in Review

Stifel Nicolaus & Co reduced its Ionis Pharmaceuticals (IONS) stake by 6.2% in Q3 2013, selling an estimated $1.24M and leaving 632,553 shares worth $23.7M. The position accounts for 0.39% of the portfolio, ranked #66.

Stifel Nicolaus & Co first reported a position in IONS in Q2 2013 and has held it in 2 quarters since. 204 funds tracked by Wall St. Rank hold IONS as of Q3 2013.

  • Stifel Nicolaus & Co held 632,553 shares of Ionis Pharmaceuticals worth $23.7M as of Q3 2013.
  • Stifel Nicolaus & Co sold 41,639 Ionis Pharmaceuticals shares in Q3 2013, an estimated $1.24M.
  • Ionis Pharmaceuticals made up 0.39% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #66 holding.
  • Stifel Nicolaus & Co first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 2 quarters since.
  • 204 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.